More women with EARLY breast cancer will be treated with an aromatase inhibitor

More women with EARLY breast cancer will be treated with an aromatase inhibitor...Arimidex, Femara, Aromasin.

Tamoxifen has been the "gold standard" to prevent recurrence in women with early estrogen receptor-positive breast cancer.

Experts now recommend most postmenopausal women get an aromatase inhibitor...either as initial therapy or after treatment with tamoxifen.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote